Ahammune Biosciences Secures $5M for Vitiligo Trialsby Lilu Anderson 25.09.2024Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Medicxi Launches Alys Pharmaceuticals in $100m Seed Fundingby Mark Eisenberg 19.02.2024Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...